Trials / Conditions / Thyroid Gland Papillary Carcinoma

Thyroid Gland Papillary Carcinoma

7 registered clinical trials studyying Thyroid Gland Papillary Carcinoma — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Personalized Cancer Support (Thrive Track) to Manage the Emotional Needs of Young Adults With Thyroid, Melanom NCT07529080	University of Michigan Rogel Cancer Center	N/A
Recruiting	Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated Thyroid Carcinoma With NCT06440850	City of Hope Medical Center	Phase 2
Terminated	Radiofrequency Ablation for the Treatment of Benign or Low Risk Thyroid Nodule NCT05003856	M.D. Anderson Cancer Center	N/A
Recruiting	Evaluation of 18F-TFB PET/CT Scan in Patients With Differentiated Thyroid Cancer NCT05575440	Mayo Clinic	—
Active Not Recruiting	Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancer NCT04759911	M.D. Anderson Cancer Center	Phase 2
Active Not Recruiting	Testing the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated T NCT03914300	National Cancer Institute (NCI)	Phase 2
Terminated	Lenvatinib and Iodine Therapy in Treating Patients With Radioactive Iodine-Sensitive Differentiated Thyroid Ca NCT03506048	Emory University	Phase 2